BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Li R, Zheng Y, Song M, Zhang S, Sun Y, Wei M, Fan X. Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats. Front Pharmacol 2022;13:854790. [DOI: 10.3389/fphar.2022.854790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yin G, Liang H, Sun W, Zhang S, Feng Y, Liang P, Chen S, Liu X, Pan W, Zhang F. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1016745] [Reference Citation Analysis]
2 Zhang SZ, Liang PP, Feng YN, Yin GL, Sun FC, Ma CQ, Zhang FX. Therapeutic potential and research progress of diosgenin for lipid metabolism diseases. Drug Dev Res 2022. [PMID: 36126194 DOI: 10.1002/ddr.21991] [Reference Citation Analysis]
3 Arya P, Kumar P. Diosgenin: An ingress towards solving puzzle for diabetes treatment. Journal of Food Biochemistry. [DOI: 10.1111/jfbc.14390] [Reference Citation Analysis]
4 Zhou D, Zhang J, Xiao C, Mo C, Ding B. Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. Front Immunol 2022;13:964477. [DOI: 10.3389/fimmu.2022.964477] [Reference Citation Analysis]